DeepMed Research

Jiangsu Province Centers for Disease Control and Prevention

People's Republic of China

Country: People's Republic of China

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.jstd.gov.cn/

Clinical Trials

The Interaction Between Mucosal Microbiota Colonization and the Immune Response to an Intranasal Influenza Live Attenuated Vaccine

Phase 4

Completed

Conditions: Influenza

Interventions: Biological: Intranasal Influenza Live Attenuated Vaccine

First Posted Date: 2024-09-24

Last Posted Date: 2025-04-24

Lead Sponsor: Jiangsu Province Centers for Disease Control and Prevention

Target Recruit Count: 200

Registration Number: NCT06609811

Locations: 🇨🇳
Haizhou District Center for Disease Control and Prevention, Lianyungang, Jiangsu, China

Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants

Not Applicable

Recruiting

Conditions: Pertussis
Diphtheria
Tetanus
Haemophilus Influenzae Type B Infection
Polio

Interventions: Procedure: Different immunization regiments with DTaP-IPV/Hib Pentavalent Vaccine

First Posted Date: 2024-09-20

Last Posted Date: 2024-09-20

Lead Sponsor: Jiangsu Province Centers for Disease Control and Prevention

Target Recruit Count: 785

Registration Number: NCT06605755

Locations: 🇨🇳
Jingsu Provincial Centre of Disease Control and Prevention, Nanjing, Jiangsu, China

Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine

Phase 4

Active, not recruiting

Conditions: Hand, Foot and Mouth Disease

Interventions: Biological: Enterovirus Type 71 Vaccine, inactivated ( Human Diploid Cell )
Biological: Recombinant Hepatitis B Vaccine
Biological: Group A meningococcal polysaccharide vaccine

First Posted Date: 2024-01-17

Last Posted Date: 2024-01-17

Lead Sponsor: Jiangsu Province Centers for Disease Control and Prevention

Target Recruit Count: 510

Registration Number: NCT06209398

Locations: 🇨🇳
Jiangsu Province Centers for Disease Control and Prevention, Nanjing, Jiangsu, China

Effectiveness of a Second COVID-19 Vaccine Booster in Chinese Adults

Phase 4

Not yet recruiting

Conditions: COVID-19

Interventions: Biological: Intramuscularly administered Ad5-nCoV vaccine
Biological: DelNS1-2019-nCoV-RBD-OPT1
Biological: SYS6006
Biological: Aerosolized Ad5-nCoV

First Posted Date: 2023-05-11

Last Posted Date: 2023-05-22

Lead Sponsor: Jiangsu Province Centers for Disease Control and Prevention

Target Recruit Count: 10000

Registration Number: NCT05855408

Locations: 🇨🇳
Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China

Immunogenicity and Safety of Subunit Vaccine of Plague Vaccine With Two Immunization Regimens

Phase 2

Conditions: Plague

Interventions: Biological: plague vaccine(F1+rV)

First Posted Date: 2022-04-15

Last Posted Date: 2022-04-15

Lead Sponsor: Jiangsu Province Centers for Disease Control and Prevention

Target Recruit Count: 720

Registration Number: NCT05330624

Locations: 🇨🇳
Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China

Clinical Evaluation for Batch Consistency of Ad5-nCoV in Chinese Healthy Adults

Phase 4

Completed

Conditions: COVID-19

Interventions: Biological: batch 2 of Ad5-nCoV
Biological: batch 1 of Ad5-nCoV
Biological: batch 3 of Ad5-nCoV

First Posted Date: 2022-04-06

Last Posted Date: 2022-04-06

Lead Sponsor: Jiangsu Province Centers for Disease Control and Prevention

Target Recruit Count: 1050

Registration Number: NCT05313646

Locations: 🇨🇳
Guanyun Center for Disease Control and Prevention, Lianyungang, Jiangsu, China

A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years

Phase 4

Completed

Conditions: Influenza

Interventions: Biological: Quadrivalent influenza vaccine

First Posted Date: 2022-04-06

Last Posted Date: 2022-08-17

Lead Sponsor: Jiangsu Province Centers for Disease Control and Prevention

Target Recruit Count: 252

Registration Number: NCT05313893

Locations: 🇨🇳
Donghai County Center for Disease Control and Prevention, Lianyungang, Jiangsu, China

Heterologous Boost Immunization with Ad5-nCoV After Three-dose Priming with an Inactivated SARS-CoV-2 Vaccine

Phase 4

Completed

Conditions: COVID-19

Interventions: Biological: Ad5-nCoV-IM
Biological: CoronaVac
Biological: Ad5-nCoV-IH

First Posted Date: 2022-03-31

Last Posted Date: 2025-02-21

Lead Sponsor: Jiangsu Province Centers for Disease Control and Prevention

Target Recruit Count: 362

Registration Number: NCT05303584

Locations: 🇨🇳
Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China

A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 Months

Phase 1

Completed

Conditions: Influenza

Interventions: Biological: quadrivalent influenza split vaccine
Biological: Influenza virus split vaccine

First Posted Date: 2022-01-28

Last Posted Date: 2022-10-28

Lead Sponsor: Jiangsu Province Centers for Disease Control and Prevention

Target Recruit Count: 120

Registration Number: NCT05212623

Locations: 🇨🇳
Jiangsu Province Centers for Disease Control and Prevention, Nanjing, Jiangsu, China

Heterologous Boost Immunization with an Aerosolised Ad5-nCoV After Two-dose Priming with an Inactivated SARS-CoV-2 Vaccine

Phase 3

Completed

Conditions: COVID-19

Interventions: Biological: Inactivated SARS-CoV-2 vaccine
Biological: Aerosolized Ad5-nCoV

First Posted Date: 2022-01-24

Last Posted Date: 2025-02-21

Lead Sponsor: Jiangsu Province Centers for Disease Control and Prevention

Target Recruit Count: 10285

Registration Number: NCT05204589

Locations: 🇨🇳
Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy